(Q38124456)

29 August 2017

title

Vascular dysfunction in preeclampsia (English)

1 reference

29 August 2017

0 references

0 references

Lesley J Brennan

1

1 reference

29 August 2017

Jude S Morton

series ordinal

2

1 reference

29 August 2017

Sandra T Davidge

series ordinal

3

1 reference

29 August 2017

publication date

1 January 2014

1 reference

29 August 2017

1 reference

29 August 2017

volume

21

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

4-14

1 reference

Matrix metalloproteinase enhances big-endothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Immunologic characteristics of preeclampsia, a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant Sprague-Dawley rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Inflammation and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Association of maternal endothelial dysfunction with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Active participation of endothelial cells in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Plasma interleukin-12 is elevated in patients with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Haemodynamics in women with untreated pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

The global impact of pre-eclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Hypertension in pregnancy: an emerging risk factor for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Low-salt diet enhances vascular reactivity and Ca(2+) entry in pregnant rats with normal and reduced uterine perfusion pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Reactive Oxygen Species Regulate Activation-Induced T Cell Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Diverse mechanisms of endothelium-derived hyperpolarizing factor-mediated dilatation in small myometrial arteries in normal human pregnancy and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Lectin-like oxidized low-density lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Molecular mechanisms of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Quantitative analysis of trophoblast invasion in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Placental growth factor is a potent vasodilator of rat and human resistance arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Low levels of hydrogen peroxide stimulate corneal epithelial cell adhesion, migration, and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Regulation of vascular endothelial growth factor expression by insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Preeclampsia: an excessive maternal inflammatory response to pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Preeclampsia: an endothelial cell disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

The role of the immune system in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Preeclampsia: current understanding of the molecular basis of vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Diagnosis and management of gestational hypertension and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Endothelial progenitor cells: their potential in the placental vasculature and related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Decrease and senescence of endothelial progenitor cells in patients with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Circulating endothelial progenitor cells during human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Differential blood flow in uterine, ophthalmic, and brachial arteries of preeclamptic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

The biology of vascular endothelial growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Preeclamptic Sera Stimulate Increased Platelet-Derived Growth Factor mRNA and Protein Expression by Cultured Human Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Circulating endothelial progenitor cells and cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

Vascular Endothelial Growth Factor Is Induced by the Inflammatory Cytokines Interleukin-6 and Oncostatin M in Human Adipose Tissue In Vitro and in Murine Adipose Tissue In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FMICC.12079

21 January 2018

Identifiers

DOI

10.1111/MICC.12079

1 reference

29 August 2017

1 reference